Skip to main content
OpenTrials

Clinical trial condition

Non-small Cell Lung Cancer (NSCLC)

Explore clinical trials studying Non-small Cell Lung Cancer (NSCLC). Study availability and eligibility vary by location and protocol.

145 public trials 47 recruiting studies
Refine in advanced search Browse all conditions

Non-small Cell Lung Cancer (NSCLC) trial results

Active, Not Recruiting

Phase 1b/2 Platform Study of Select Immunotherapy Combinations in Participants With Advanced Non-small Cell Lung Cancer (NSCLC)

NCT06162572

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Loma Linda University Loma Linda, California, United States
  • Henry Ford Health Detroit, Michigan, United States
  • Comprehensive Cancer Center of Nevada Las Vegas, Nevada, United States
  • Gabrail Cancer Center Canton, Ohio, United States
View all 63 locations
View Trial Details
Active, Not Recruiting

A Study of Brigatinib as Preferred First Therapy for Adults With Non-Small Cell Lung Cancer (NSCLC) ENTIRETY

NCT05735327

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Dolnoslskie Centrum Onkologii, Pulmonologii i Hematologii Wroclaw, Dolnoslskie, Poland
  • Szpital Kliniczny im. Heliodora Swiecickiego UM wPoznaniu. Poznan, Greater Poland Voivodeship, Poland
  • Wielkopolskie Centrum Pulmonologii i Torakochirurgii w Poznaniu Poznan, Greater Poland Voivodeship, Poland
  • Centrum Onkologii im.Prof. F. Lukaszczyka w Bydgoszczy Bydgoszcz, Kuyavian-Pomeranian Voivodeship, Poland
View Trial Details
Active, Not Recruiting

Study of Furmonertinib in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) With Activating, Including Uncommon, Epidermal Growth Factor Receptor (EGFR) or Human Epidermal Growth Factor Receptor 2 (HER2) Mutations

NCT05364073

Conditions
Advanced Non-Small Cell Lung Cancer, Bronchial Neoplasms, Carcinoma, Bronchogenic, +13 more
Locations
  • ArriVent Investigative Site Prescott, Arizona, United States
  • ArriVent Investigative Site Sacramento, California, United States
  • ArriVent Investigative Site Whittier, California, United States
  • ArriVent Investigative Site Celebration, Florida, United States
View all 42 locations
View Trial Details
Active, Not Recruiting

U3-1402 in Metastatic or Unresectable Non-Small Cell Lung Cancer

NCT03260491

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +12 more
Locations
  • City of Hope Duarte, California, United States
  • University of California San Diego La Jolla, California, United States
  • Pacific Shores Medical Group Long Beach, California, United States
  • Winship Cancer Institute of Emory University Atlanta, Georgia, United States
View all 37 locations
View Trial Details
Active, Not Recruiting

Study of RP1 Monotherapy and RP1 in Combination With Nivolumab (IGNYTE)

NCT03767348

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +22 more
Locations
  • University of Birmingham Alabama Birmingham, Alabama, United States
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • Mayo Clinic Phoenix, Arizona, United States
  • Carti Cancer Center Little Rock, Arkansas, United States
View all 51 locations
View Trial Details

Related conditions